Leharso, Noralyn S.

HRN: 21-23-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/14/2022
04/21/2022
IV
500
Q8
PROPHYLAXIS

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: